Search

Your search keyword '"Vaishnaw A"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Vaishnaw A" Remove constraint Author: "Vaishnaw A" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
40 results on '"Vaishnaw A"'

Search Results

3. Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases

6. Investigating the Risk of Airborne COVID-19 and the Importance of Social Restrictions in Regulating the Transmission

11. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

14. Mathematical model on Post-COVID pulmonary fibrosis: A case study on a COVID patient.

16. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

19. GC-MS Analysis of Ichnocarpus frutescens (L.) W.T. Aiton Root Hydro-Alcoholic Extract

20. Oil extraction, biochemical activities and in silico analysis for active compound valorization in Azardiricta indica seeds and production of microbial oil using Saccharomyces cerevisiae

21. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

22. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

23. Data from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

24. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

25. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

26. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

27. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

28. Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy

30. Continuous Evolution for 5G: Comprehensive Study and Challenges

35. Exploring various long-term side effects of COVID 19 after recovery using computational simulations of a mathematical model.

36. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

37. Formulation And Development Of Topical Bupivacaine Drug Delivery Systems For Pain Management.

38. Computational Simulation of the Effect of Increase in the Estrogen level on the Normal- Tumour- Immune- Unhealthy Diet Model for breast cancer

39. Multi Objective Flexible Employee Scheduling for Pharmaceutical Industries Using Hybrid Genetic Algorithm.

40. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human

Catalog

Books, media, physical & digital resources